ClinicalTrials.Veeva

Menu

Oral and Gut Microbiota Changes During Long-term Fasting in Humans (OralFast)

B

Buchinger Wilhelmi Development

Status

Completed

Conditions

Periodontitis
Healthy

Treatments

Procedure: Long-term fasting

Study type

Interventional

Funder types

Other

Identifiers

NCT05449249
BuWi_OralFast_2022

Details and patient eligibility

About

The aim of this longitudinal trial is to investigate the effects of a 10±3-day fasting period in 30 subjects. Changes in the oral and gut microbiota, halitosis, as well as inflammatory and antioxidative parameters and biomarkers of sulfur metabolism will be analysed.

Full description

Fasting has been linked with changes in gut microbiota as part of the physiological adaptation. Furthermore, associations have been described between oral disease and nutrition (diet rich in carbohydrates). The aim of the present longitudinal clinical study is to explore the effect of a 10±3-day fasting period on the oral and gut microbiota. 30 systemically healthy subjects attending the Buchinger Wilhelmi Clinics for fasting, will participate. Changes in oral microbiota will be assessed in plaque and saliva samples and a number of inflammatory markers will be analyzed in Gingival Crevicular fluid (GCF) and blood obtained before, during and after the fasting period. The changes in the oral microbiota will be associated to the composition of the gut microbiota. Changes in periodontal parameters and halitosis related to the fasting period will be further evaluated. Given the known association between sulfur metabolism and the redox status, parameters from the antioxidant status and oxidative damages will also be assessed.

Enrollment

36 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Both subjects with periodontitis and healthy periodontium will be included.
  • Signed informed consent

Exclusion criteria

  • Not able to sign the informed consent
  • diagnosticated with cachexia, anorexia, nervosa, advanced kidney, liver or cerebrovascular insufficiency
  • Smoking
  • the intake of antibiotics within the last 8 weeks, as well as the intake of probiotics within the last 4 weeks
  • periodontal treatment in the last 6 months
  • chronic manifest psychical and psychiatric diseases
  • participation in another study
  • pregnancy or breastfeeding

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

36 participants in 1 patient group

Long-term fasting
Experimental group
Description:
Long-term fasting according to the Buchinger Wilhelmi fasting program.
Treatment:
Procedure: Long-term fasting

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems